Perth Biotech hopes to help family dogs that treat cancer and has opened up 36 clinical trials of anticancer products. Following ratification by the Animal Care and Ethics Committee of New South Wales, Perth Biotech was approved to implement its PPL-1 product as a last resort for dogs and cancer. Perfume Fine Mist Long Nozzles Perfume Fine Mist Long Nozzles,Perfume Crimp Pump,Metal Shape Perfume Nozzle,Sprayer Atomizer Nozzle Zhangjiagang XinYe Chemical Sprayer Co., Ltd. , https://www.xinyesprayer.com
The company hopes that the product can be very early in the human trial phase, has an Adelaide-based patient involved, and will slow growth, leading to retrograde type of advanced tumors. Because dogs cannot be cured with melanoma, double-soft tissue sarcoma, and chemotherapy-resistant lymphoma, they are currently being tested.
Executive chairman Roger Aston said, "Eligible dogs need to fail to take care of all the criteria and try out all human therapeutic methods available. We found this to be a very effective animal model like mice. But when we With a compassionate study, we found that the product actually tastes terrible, even if you mix it with your favorite food.So we changed it to liquid form soft capsules such as fish oil capsules, and the dog is taking very it is good."
He said that the study will be based in Sydney, but if a desperate pet owner wants to move to test, they will not say no. The market for dogs in cancer treatment is estimated to cost about 550 million U.S. dollars in the United States.